BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180709
DTEND;VALUE=DATE:20180711
DTSTAMP:20260515T051658
CREATED:20180319T122636Z
LAST-MODIFIED:20180319T122953Z
UID:12647-1531094400-1531267199@www.pharmajournalist.com
SUMMARY:ADMET
DESCRIPTION:CONFERENCE CHAIR: Eric Bloome\, Vice President\, Global Pre-Clinical Safety Senior Research Fellow\, AbbVie \n\nSMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th – 10th July 2018\, featuring. \nDevelopments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost\, and minimise production times. \nThe growing use of ADMET technologies is driving the market growth\, which is estimated to reach $14\,319.9 Million by 2022\, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage. \n*Source: http://bit.ly/2hMJcgU \nThis event is CPD accredited. \nSpeaker Line-Up includes: Pau Aceves\, Peter Littlewood\, Filipe Lopes\, Andreas Reichel\, Laurent Salphati\, Timothy Schulz-Utermoehl\, Kunal Taskar\, Robert Van Waterschoot\, Ian Wilson. \nEarly bird offers available! \nFor details and to register\, visit the website at www.admet-event.com  or contact the team at +44(0) 207 827 6000\, email ssapal@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/admet/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180710
DTEND;VALUE=DATE:20180713
DTSTAMP:20260515T051658
CREATED:20180511T110503Z
LAST-MODIFIED:20180511T110540Z
UID:15775-1531180800-1531439999@www.pharmajournalist.com
SUMMARY:IMPACCT: mHealth
DESCRIPTION:IMPACCT: mHealth 2018 is a unique dedicated forum where industry and clinical leaders can delve into clinical transformation in the making. \nProviding fresh insights into how leading pharmaceutical companies and clinical research organizations are actually transforming clinical trials with mobile and digital technology\, IMPACCT: mHealth looks beyond the theory or future promises\, to focus specifically on real-world examples and learnings that will help drive the implementation of mHealth and digital tools in clinical programs\, and overcome key operational\, regulatory and strategic challenges. \nAlong with over 90+ senior level experts from large pharma\, innovative biotech\, pioneering academia and expert solution providers\, this meeting will enable you to discover how they are accelerating clinical R&D\, promoting patient-centricity and advancing the use of patient-facing data. \nHow is mHealth and digital actually changing the way clinical trials are planned\, run and delivered today? \n What has changed\, and what will change around how mobile technology can disrupt the traditional clinical R&D model? \nThese are the questions to be explored and answered in this collaborative discussion. You’ll be able to hear the latest case-studies in this space\, and explore in full the applications and limitations of mobile and digital innovation in the context of clinical programs – with exclusive insights from organizations such as Pfizer\, Novartis\, CTTI\, Duke-Margolis Center for Health Policy\, Takeda\, AbbVie\, The Michael J. Fox Foundation\, UCB\, Eli Lilly or GSK. \nThese are exciting times for everyone actively involved in the efforts to bring the use of mHealth technologies in clinical research to the next level!
URL:https://www.pharmajournalist.com/event/impacct-mhealth/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="HansonWade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR